Back

Association of SGLT2-inhibitor and GLP1-receptor agonist use with clinical outcomes in aortic stenosis: a large-scale propensity-matched study

28 August 2026 (15:00 - 15:15)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award Session in Valvular Heart Disease Aortic Valve Stenosis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Yashika Relan

Dundee (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Multivalvular heart disease and outcomes after transcatheter aortic valve implantation: updated results from the MIRA study
Doctor C. Schulz (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Natural history, cardiac remodeling, and prognostic stratification in aortic regurgitation quantified by cardiovascular magnetic resonance
Doctor Z. Li (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Impact of intraoperative metagenomic next-generation sequencing on long-term outcomes in patients with blood culture–negative infective endocarditis
Mr L. Zhang (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award Session in Valvular Heart Disease
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 15:00 CET
You may be interested in
thumbnail
Congress Presentation
EMPagliflozin after Aortic Valve Replacement study: a randomized clinical trial
28 August 2026
thumbnail
Congress Session
Young Investigator Award (YIA) Clinical Cardiology
12 May 2024
thumbnail
Congress Session
Exploring valvular and congenital heart disease with cardiac magnetic resonance
31 August 2024
thumbnail
Congress Presentation
Aortic stenosis and heart failure: optimal therapeutic approach?
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources